Skip to main content
. 2001 Dec;45(12):3427–3432. doi: 10.1128/AAC.45.12.3427-3432.2001

TABLE 2.

RT-PCR ELISA for detection of transient infection of human A431 cells with HPV-11 or HPV-40a

Expt and treatment (μg/ml)b Mean (SD) of OD reading for RT-PCR ELISA
HPV probe β-Actin probe
Expt 1
 Cells alone 0.043 (0.004) 1.645 (0.052)
 HPV-11 only 1.417 (0.063) 1.564 (0.051)
 Without virus
  CS (1,000) 0.028 (0.004) 1.427 (0.013)
  DS (1,000) 0.000 (0.000) 1.470 (0.001)
  PSS (1,000) 0.038 (0.001) 1.467 (0.158)
 With virus
  CS (1,000) 0.038 (0.001) 1.518 (0.020)
  CS (100) 0.049 (0.001) 1.532 (0.025)
  CS (10) 1.485 (0.045) 1.576 (0.021)
  DS (100) 0.035 (0.000) 1.583 (0.022)
  DS (10) 0.023 (0.000) 1.636 (0.105)
  PSS (1,000) 0.045 (0.001) 1.565 (0.040)
  PSS (100) 0.036 (0.002) 1.585 (0.022)
  PSS (10) 0.011 (0.004) 1.629 (0.057)
Expt 2
 With virus
  PSS (100) 0.008 (0.006) 1.002 (0.186)
  PSS (10) 1.045 (0.016) 1.094 (0.074)
  PSS (1) 0.893 (0.100) 0.145 (0.015)
  PSS (0.1) 0.714 (0.026) 1.171 (0.042)
Expt 3
 With virus
  CS (1,000) 0.037 (0.004) NDc
  CS (100) 0.128 (0.008) ND
  CS (10) 0.397 (0.050) ND
  DS (1,000) 0.006 (0.007) ND
  DS (100) 0.375 (0.073) ND
  DS (10) 0.042 (0.007) ND
  PSS (1,000) 0.002 (0.003) ND
  PSS (100) 0.732 (0.047) ND
  PSS (10) 1.729 (0.384) ND
 HPV-40 only 1.320 (0.074) ND
a

Human A431 cells were infected with HPV-11 (experiments 1 and 2) or HPV-40 (experiment 3), and HPV-11 probe (experiments 1 and 2) or HPV-40 probe (experiment 3) was used. Two additional experiments yielded similar results. 

b

Concentrations shown are the viral pretreatment doses for CS, DS, and PSS. 

c

ND, not determined.